Over the last five years, the stock has decreased in 56% of these instances, with a median decline of -3.1% and a maximum ...

Eli Lilly said on Thursday that its newer diabetes drug Mounjaro outperformed Trulicity, its previously top-selling ...

Eli Lilly said it believes the new data bolsters the case for Mounjaro to be prescribers’ first choice for patients with Type ...

Eli Lilly said on Thursday that its newer diabetes drug Mounjaro outperformed Trulicity, its previously top-selling ...

Eli Lilly drug Mounjaro resulted in a lower risk of heart attacks and strokes in patients with diabetes compared with the ...

Eli Lilly & Co.’s blockbuster diabetes drug Mounjaro was about as good at preventing heart attacks and strokes as its older ...

你是不是也经常听到身边的朋友或家人抱怨，糖尿病不仅让他们每天都要小心翼翼地控制饮食，还要时刻担心心脏病的风险？这可不是杞人忧天。心血管疾病仍然是2型糖尿病患者的主要死因。但好消息来了，Eli Lilly公司的一款新药Mounjaro在最近的一项临床试验中大放异彩，可能会成为他们的新希望。 GLP-1受体激动剂，比如诺和诺德的Ozempic，已经证明能有效降低2型糖尿病患者的血糖水平，并且还能减少心 ...

ABC News Medical Correspondent Dr. Darien Sutton take a closer look at the new study by Eli Lilly that their popular diabetes drug Mounjaro showed heart protection benefits.

Eli Lilly's Mounjaro shows significant cardiovascular benefits in a major trial enhancing treatment options for type 2 ...

CNBC's Angelica Peebles joins 'Squawk Box' with the latest news from Eli Lilly. Why South Park Did an About-Face on Mocking ...

Eli Lilly’s blockbuster diabetes drug Mounjaro matched the ability of an older treatment to prevent major heart complications ...

Eli Lilly's growth is fueled by GLP-1 blockbusters and a solid pipeline, yet high valuations and reliance on key drugs ...